Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable IL28B Allele-Prevalent Area | Zendy

Hyun Jung Chung | Zendy; JinWoo Lee | Zendy; Young Soo Kim | Zendy; Jung Il Lee | Zendy

Open Access

Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable <b><i>IL28B</i></b> Allele-Prevalent Area

Author(s) -

Hyun Jung Chung,

JinWoo Lee,

Young Soo Kim,

Jung Il Lee

Publication year - 2013

Publication title -

intervirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.641

H-Index - 61

eISSN - 1423-0100

pISSN - 0300-5526

DOI - 10.1159/000345539

Subject(s) - ribavirin , medicine , gastroenterology , hepatitis c virus , cirrhosis , genotype , viral load , virus , virology , biology , gene , biochemistry

The aim of this study was to evaluate rapid virologic response (RVR) rate after peginterferon (PegIFN) and ribavirin (RBV) dual combination therapy in Korean hepatitis C virus (HCV) genotype 1 patients whose IL28B polymorphism is generally favorable. This study also assessed the value of RVR in predicting sustained virologic response (SVR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research